377 related articles for article (PubMed ID: 23404189)
1. Platelet function profiles in patients with diabetes mellitus.
Rollini F; Franchi F; Muñiz-Lozano A; Angiolillo DJ
J Cardiovasc Transl Res; 2013 Jun; 6(3):329-45. PubMed ID: 23404189
[TBL] [Abstract][Full Text] [Related]
2. Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.
Capranzano P; Capodanno D
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):307-17. PubMed ID: 23469911
[TBL] [Abstract][Full Text] [Related]
3. Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
Ferreiro JL; Angiolillo DJ
Curr Pharm Des; 2012; 18(33):5273-93. PubMed ID: 22724415
[TBL] [Abstract][Full Text] [Related]
4. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.
Watala C
Curr Pharm Des; 2005; 11(18):2331-65. PubMed ID: 16022671
[TBL] [Abstract][Full Text] [Related]
5. The platelet in diabetes: focus on prevention of ischemic events.
Colwell JA; Nesto RW
Diabetes Care; 2003 Jul; 26(7):2181-8. PubMed ID: 12832332
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy in patients with diabetes mellitus.
Grove EL; Gregersen S
Curr Vasc Pharmacol; 2012 Jul; 10(4):494-505. PubMed ID: 22272895
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
[TBL] [Abstract][Full Text] [Related]
9. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J
Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541
[TBL] [Abstract][Full Text] [Related]
10. Platelet dysfunction in central obesity.
Anfossi G; Russo I; Trovati M
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):440-9. PubMed ID: 19346117
[TBL] [Abstract][Full Text] [Related]
11. Platelet function testing and tailored antiplatelet therapy.
Janssen PW; ten Berg JM
J Cardiovasc Transl Res; 2013 Jun; 6(3):316-28. PubMed ID: 23543615
[TBL] [Abstract][Full Text] [Related]
12. Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome.
Anfossi G; Russo I; Trovati M
Curr Vasc Pharmacol; 2008 Oct; 6(4):313-28. PubMed ID: 18855719
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?
Chouchene S; Dabboubi R; Raddaoui H; Abroug H; Ben Hamda K; Hadj Fredj S; Abderrazak F; Gaaloul M; Rezek M; Neffeti F; Hellara I; Sassi M; Khefacha L; Sriha A; Nouira S; Najjar MF; Maatouk F; Messaoud T; Hassine M
Eur J Clin Pharmacol; 2018 Dec; 74(12):1567-1574. PubMed ID: 30073432
[TBL] [Abstract][Full Text] [Related]
14. Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.
Watala C; Boncler M; Gresner P
Pharmacol Rep; 2005; 57 Suppl():42-58. PubMed ID: 16415486
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
Sepúlveda C; Palomo I; Fuentes E
Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
[TBL] [Abstract][Full Text] [Related]
16. Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
Angiolillo DJ; Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Sumner S; Desai B; Charlton RK; Box LC; Zenni M; Guzman LA; Bass TA
Thromb Haemost; 2011 Aug; 106(2):253-62. PubMed ID: 21614414
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
Angiolillo DJ; Bernardo E; Capodanno D; Vivas D; Sabaté M; Ferreiro JL; Ueno M; Jimenez-Quevedo P; Alfonso F; Bass TA; Macaya C; Fernandez-Ortiz A
J Am Coll Cardiol; 2010 Mar; 55(11):1139-46. PubMed ID: 20223369
[TBL] [Abstract][Full Text] [Related]
18. Platelets and diabetes mellitus.
Mustard JF; Packham MA
N Engl J Med; 1977 Dec; 297(24):1345-7. PubMed ID: 917091
[No Abstract] [Full Text] [Related]
19. The role of calpain in diabetes-associated platelet hyperactivation.
Randriamboavonjy V; Fleming I
Adv Pharmacol; 2010; 59():235-57. PubMed ID: 20933204
[TBL] [Abstract][Full Text] [Related]
20. Platelets and antiplatelet therapy in patients with diabetes mellitus.
Arjomand H; Roukoz B; Surabhi SK; Cohen M
J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
